Procter & Gamble Company
$ 144.55
0.20%
14 Aug - close price
- Market Cap 335,996,813,000 USD
- Current Price $ 144.55
- High / Low $ 144.91 / 143.41
- Stock P/E 21.84
- Book Value 22.95
- EPS 6.62
- Next Earning Report -
- Dividend Per Share $4.26
- Dividend Yield 2.95 %
- Next Dividend Date 2026-08-17
- ROA 0.11 %
- ROE 0.30 %
- 52 Week High 164.77
- 52 Week Low 134.62
About
The Procter & Gamble Company (P&G) is an American multinational consumer goods corporation headquartered in Cincinnati, Ohio, founded in 1837 by William Procter and James Gamble. It specializes in a wide range of personal health, consumer health, personal care, and hygiene products; these products are organized into several segments including Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine, & Family Care. Before the sale of Pringles to Kellogg's, its product portfolio also included food, snacks, and beverages.
Analyst Target Price
$160.57
Quarterly Earnings
| Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-07-29 | 2026-04-24 | 2026-01-22 | 2025-10-24 | 2025-07-29 | 2025-04-24 | 2025-01-22 | 2024-10-18 | 2024-07-30 | 2024-04-19 | 2024-01-23 | 2023-10-18 |
| Reported EPS | 1.43 | 1.59 | 1.88 | 1.99 | 1.48 | 1.54 | 1.88 | 1.93 | 1.4 | 1.52 | 1.84 | 1.83 |
| Estimated EPS | 1.41 | 1.56 | 1.86 | 1.9 | 1.42 | 1.53 | 1.86 | 1.9 | 1.37 | 1.41 | 1.7 | 1.72 |
| Surprise | 0.02 | 0.03 | 0.02 | 0.09 | 0.06 | 0.01 | 0.02 | 0.03 | 0.03 | 0.11 | 0.14 | 0.11 |
| Surprise Percentage | 1.4184% | 1.9231% | 1.0753% | 4.7368% | 4.2254% | 0.6536% | 1.0753% | 1.5789% | 2.1898% | 7.8014% | 8.2353% | 6.3953% |
Next Quarterly Earnings
| Reported Date |
| Fiscal Date Ending |
| Estimated EPS |
| Currency |
Previous Dividend Records
| Aug 2026 | May 2026 | Feb 2026 | Nov 2025 | Aug 2025 | May 2025 | Feb 2025 | Nov 2024 | Aug 2024 | May 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Payment Date | 2026-08-17 | 2026-05-15 | 2026-02-17 | 2025-11-17 | 2025-08-15 | 2025-05-15 | 2025-02-18 | 2024-11-15 | 2024-08-15 | 2024-05-15 |
| Amount | $1.0885 | $1.0885 | $1.0568 | $1.0568 | $1.0568 | $1.0568 | $1.0065 | $1.0065 | $1.0065 | $1.0065 |
Next Dividend Records
| Dividend per share (year): | $4.26 |
| Dividend Yield | 2.95% |
| Next Dividend Date | 2026-08-17 |
| Ex-Dividend Date | 2026-07-24 |
Recent News: PG
2026-08-15 09:42:41
Stolper Co significantly reduced its stake in Procter & Gamble (NYSE:PG) by 69.7% in the second quarter, selling 32,604 shares and retaining 14,159 shares valued at $2.08 million. Despite this, institutional investors collectively own 65.77% of PG, and analysts generally maintain a "Moderate Buy" rating with an average price target of $161.52. Procter & Gamble recently beat EPS estimates and declared a quarterly dividend of $1.0885 per share, offering a 3.0% annual yield.
2026-08-15 08:10:35
Accurate Wealth Management LLC significantly increased its holdings in Procter & Gamble (NYSE:PG) by 108.4% in the second quarter, bringing its total stake to $27.69 million, representing 2.6% of its portfolio. The article details P&G's recent financial performance, including its Q2 EPS of $1.43, revenue of $21.20 billion, and a declared quarterly dividend of $1.0885. Analysts maintain a "Moderate Buy" rating for P&G, with an average price target of $161.52.
2026-08-15 07:09:24
Altium Investment Strategies LLC has acquired 100,702 shares of Procter & Gamble (NYSE:PG), valued at approximately $14.8 million, making it their second-largest holding. Institutional investors collectively own 65.77% of PG stock. Despite revenue falling short of estimates, PG beat EPS expectations in its latest quarter and maintained its fiscal 2027 EPS guidance.
2026-08-14 19:35:12
Procter & Gamble (PG) is gaining renewed attention after extending its dividend growth streak to 70 years and acquiring Thorne for $3.8 billion. Despite these positive developments, the stock's one-year return has been modest. Valuation models offer mixed signals, with one suggesting it's overvalued at $107.50 and another indicating it's undervalued at $201.56, creating a wide range for its fair value.
2026-08-14 12:03:26
This "Rx Rundown" article details significant medical marketing news, dealmaking, and industry chatter from the past week. Key highlights include major acquisitions by KKR, Eli Lilly, and Procter & Gamble, as well as numerous partnerships, FDA approvals and rejections, and substantial funding rounds for various biopharma companies. The report also covers industry news such as clinical trial results, workforce reductions, and regulatory actions.
2026-08-14 11:10:05
Y Intercept Hong Kong Ltd significantly increased its stake in Procter & Gamble (NYSE:PG) by 218.3% in the second quarter, acquiring an additional 35,223 shares to bring its total holdings to 51,360 shares valued at approximately $7.5 million. Despite analysts maintaining a "Moderate Buy" rating with an average price target of $161.52, P&G faces risks from weaker earnings forecasts and pressure on consumer spending, even as it continues to be viewed as a defensive Dividend King with a 3.0% yield. The company slightly surpassed quarterly EPS expectations but fell short on revenue estimates.
